Atopic Dermatitis-Like Skin Disease in Pediatric Heart Transplant Patients

Last updated: February 1, 2013
Sponsor: Hordinsky, Maria K., MD
Overall Status: Terminated

Phase

3

Condition

Allergies & Asthma

Allergy

Atopic Dermatitis

Treatment

N/A

Clinical Study ID

NCT00176956
0110M09983
  • Ages < 16
  • All Genders

Study Summary

The skin disease found in pediatric heart transplant patients represents an atopic dermatitis-like rash that is refractory to systemic immunomodulation.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients must have had a heart transplant.

  • Patients must be less than 16 years of age.

Exclusion

Exclusion Criteria:

  • Patients who have not had a heart transplant.

  • Patients who are greater than 16 years of age.

Study Design

Total Participants: 30
Study Start date:
November 01, 2002
Estimated Completion Date:
January 31, 2007

Study Description

We want to determine whether pediatric heart transplant patients with an atopic dermatitis-like rash report a personal and/or family history of atopy (asthma, allergies and atopic dermatitis). In addition comparisons will be made between the presence of atopy between patients with and without the skin rash. Comparisons will be made of systemic immunosuppressive therapies between patients with and without the atopic dermatitis-like rash. Determination will be made as to whether histologic characterization of a skin biopsy specimen is consistent with AD. Thorough evaluations will be made of patients in the clinic with this rash and the presence of bacterial superinfection will be ruled out.

Connect with a study center

  • University of Minnesota

    Minneapolis, Minnesota 55455
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.